reports
Moody's announces completion of a periodic review of ratings of Eli Li...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Eli Lilly and Company. Global Credit Research- 10 Nov 2021. New York, November 10, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Eli Lilly and Company and other ratings that are associated with the same analytical unit.
Moody's rates Eli Lilly's notes A2; stable outlook
Rating Action: Moody's rates Eli Lilly's notes A2; stable outlook. Global Credit Research- 08 Sep 2021. New York, September 08, 2021-- Moody's Investors Service assigned an A2 rating to the new euro and sterling-denominated senior unsecured notes of Eli Lilly and Company.
- Andy Smith
Encouraging AGM and M3 updates
Destiny’s recent announcement on the progress on its lead asset NTCD-M3 maintains the momentum that has built since the acquisition of M3 in 2020. In addition, while the AGM narrative did not promise a licensing transaction on either of Destiny’s Phase 3-ready assets, the timelines for partnerships in 2021 and the Phase 3 studies starting in 2022 remain intact. Destiny also welcomes the recent G7 Health Ministers’ Meeting communique on 4 June and its strong message highlighting the global thre...
Moody's announces completion of a periodic review of ratings of Eli Li...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Eli Lilly and Company. Global Credit Research- 15 Dec 2020. New York, December 15, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Eli Lilly and Company and other ratings that are associated with the same analytical unit.
- MarketLine Department
Celgene Corporation - Strategy, SWOT and Corporate Finance Report
Summary Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Celgene Corporation (Celgene or 'the company') is a biopharmaceutical company that produces and sells novel therapies for the treatment of inflammatory diseases and cancer through next-gen...
- MarketLine Department
Allergan plc - Strategy, SWOT and Corporate Finance Report
Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Allergan plc (Allergan or 'the company') is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine ...
- MarketLine Department
Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnership...
Summary Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celldex Therapeutics, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdow...
- MarketLine Department
Spectral Medical Inc. - Mergers & Acquisitions (M&A), Partnerships & A...
Summary Marketline's Spectral Medical Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Spectral Medical Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the o...
- MarketLine Department
Celgene Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances ...
Summary Marketline's Celgene Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celgene Corp since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorgan...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.